Hormone Therapy for Prostate Cancer Rye NY

Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found. The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

Local Companies

Jerald Siegel
(201) 342-6600
20 Prospect Avenue
Hackensack, NJ
Israel Franco
(914) 285-8628
160 North Midland Ave
Nyack, NY
Sei Yoon
(718) 335-3333
7521 Broadway
Flushing, NY
Shanwan Chen
(718) 334-5970
80th St And 41st Ave
Elmhurst, NY
John DeFilippi
(631) 423-4775
20 Glenview Pl
Huntington, NY
Kevin Basralian
(201) 343-0082
20 Prospect Ave # 719
Hackensack, NJ
Joseph Putignano
(914) 793-1200
26 Pondfield Rd W
Bronxville, NY
Arthur Smith
(718) 343-7500
270-05 76th Avenue
New Hyde Park, NY
George E Homsy
(718) 672-3600
62-77 W Woodhaven Blvd
Flushing, NY
Sheldon Rudansky
(516) 663-2490
96 Third St
Garden City, NY
Data Provided by:
  

Provided By:

TUESDAY, Sept. 22 (HealthDay News) -- Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found.

The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

The study findings were scheduled to be presented Tuesday at the European Cancer Organization meeting in Berlin.

In a news release from the European Cancer Organization, the researchers described the types of hormone therapy used: removal of the testicles to eliminate the main source of testosterone production; injections of gonadotropin-releasing hormone agonists to reduce testosterone production by the testicles; and anti-androgen pills that block testosterone from attaching to prostate cells. Most of the patients received one treatment, but 38 percent were given two types of drugs, the study authors noted.

The men were followed for an average of three years and monitored for ischemic heart disease, heart attacks, arrhythmia, and heart failure.

"We found that prostate cancer patients treated with hormone therapy had an elevated risk of developing all of the individual types of heart problems and that they were more likely than normal to die from those causes," study lead author Mieke Van Hemelrijck, a cancer epidemiologist at King's College in London, England, said in the news release.

Specifically, hormone therapy was associated with a 24 percent increased risk of heart attack, a 19 percent increased risk of arrhythmia, a 31 percent increased risk of ischemic heart disease, and a 26 percent increased risk of heart failure, the researchers found. The increased risk of heart disease began a few months after the men began hormone therapy.

The study also found that hormone therapy was associated with a 28 percent increased risk of fatal heart attack, a 21 percent increased risk of dying from heart disease, a 26 percent increased risk of death from heart failure, and a 5 percent increased risk of fatal arrhythmia.

"In a more detailed analysis by type of hormone therapy, the lowest increase in risk for ischemic heart disease, heart attack and heart failure was seen in the group taking anti-androgen therapy, and we saw no increase in risk of death from heart disease in this group. Patients on gonadotropin-releasing hormone agonist therapy had the highest risk of these problems," Van Hemelrijck said.

The findings suggest that physicians should consider heart-related side effects when prescribing hormone therapy for prostate cancer patients and may want to refer patients to a cardiologist before the start of hormone therapy, the researchers stated.

More information

The American Urological Association Foundation has more about hormone therapy for prostate cancer.

SOURCE: European Cancer Organization, news release, Sept. 22, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Delayed Prostate Cancer Therapy Rye NY
The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.
- Exercise for Prostate Cancer Rye NY
- Hormone Therapy for Lung Cancer Rye NY
- Open Prostatectomy Versus Laparoscopic Procedure Rye NY
- Diagnosis of Prostate Cancer Rye NY
- Hormone Therapy for Breast Cancer Rye NY
- Head and Neck Cancer Treatment Rye NY
- Hormone Therapy Rye NY
- Hormone Therapy for Early Prostate Cancer Rye NY
- Menopausal Hormone Therapy Rye NY